查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1557332

血糖试纸市场－2024年至2029年预测

Blood Glucose Test Strips Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 124 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

血糖试纸市场预计将从2024年的135.67亿美元成长到2029年的178.28亿美元，成长率为5.61%（复合年增长率）

血糖试纸是用来检查血液中血糖浓度的塑胶试纸。当血液样本放置在试纸条的一端时，它会与一种称为葡萄糖氧化酵素的化学物质发生反应，产生葡萄糖酸。然后测量演算法分析这种酸以确定血糖值。

推动此类医疗器材市场扩大的主要因素是糖尿病患者数量的增加，其次是血糖监测技术的提高和自我健康意识的提高。此外，市场参与者积极投资新试纸的推出，进一步引领市场的上升轨迹。

然而，在製造试纸时使用塑胶引起了人们对此类工具的环境担忧，从而阻碍了整体市场的成长。同样，食品药物管理局（FDA）等主要权威机构对试纸生产和使用的严格规定也提高了产品的技术水准。

血糖检测试纸市场驱动因素：

  • 糖尿病盛行率的增加预计将推动整体市场的扩张。

糖尿病是全球主要死亡原因之一，I型和II型糖尿病的发生率在主要国家显着增加。全球糖尿病盛行率的不断上升被认为是血糖试纸市场成长的关键驱动力，因为糖尿病治疗需要持续监测血糖值。

据国际糖尿病联盟称，到 2030 年，将有近 6.43 亿人患有糖尿病。 2045年，这一数字将达到7.83亿人，其中2型糖尿病是主要类型。而且，根据同一资讯来源，在欧洲等主要地区，95%的糖尿病患者患有II型糖尿病，到2030年，糖尿病患者总数将达到6700万，而2021年为6100万。

世界卫生组织 (WHO) 等主要卫生组织表示，大多数糖尿病病例发生在低收入和中等收入国家。因此，这些国家需要负担得起的检测方案来监测血糖浓度。血糖试纸在低收入和中等收入国家有很大的市场，因为与基于感测器的监测仪相比，它们是一种负担得起的选择。

  • 政府加强糖尿病监测的有利倡议预计将推动市场成长。

与其他选择相比，血糖试纸易于使用、高度准确且价格实惠。与需要医疗干预的基于感测器的糖尿病测试设备不同，血糖试纸设备可以由个人使用。

由于生活方式的改变以及患有糖尿病的成人和儿童人数的增加，各国政府和主要医疗机构正在推出加强常规糖尿病筛检的策略和计划。例如，2022年11月，欧洲议会通过了欧盟范围内的糖尿病策略，以支持糖尿病的诊断、研究和治疗。

同样，根据 PIB 2023 年 8 月的公告，印度政府与卫生和家庭福利部合作，宣布根据「国家卫生使命」向各邦和中央直辖区提供技术和财政支持。此举旨在加强对包括糖尿病在内的常见非传染性疾病的预防和筛检。

  • 人们对糖尿病的认识不断提高正在推动市场扩张。

血糖值试纸比其他选择具有优势，例如更容易使用、更准确且更实惠。糖尿病检测是所有年龄层最常见的预防措施之一。随着 COVID-19 的出现，预防措施进一步加强，因为它对糖尿病和严重气喘患者有生命危险。因此，检测次数增多，血糖试纸的使用量也随之增加。

此外，成年人口的快速成长等其他因素也刺激了市场扩张，因为成年人口占全球糖尿病人口的主要份额。例如，根据 2023 年 11 月《糖尿病研究与临床实务》发表的一项研究显示，华人成人糖尿病患者占全球的主要比例。

血糖试纸市场的地域展望

  • 亚太地区占主要市场占有率

全球血糖试纸市场分为北美、南美、欧洲、中东和非洲，预计亚太地区将占据重要的市场占有率。

根据国际糖尿病联盟预测，2030年，亚太地区的糖尿病人口将占全球的54%，2045年将占到52%。同样，根据印度医学研究委员会发布的「印度糖尿病」研究报告，该国糖尿病患者人数已达1.01亿人。此外，根据澳洲糖尿病协会的数据，截至2023年9月，约有150万澳洲人患有糖尿病，其中II型糖尿病占总数的86.7%。据同一资讯来源称，过去 12 个月新登记病例数为 113,907 例。

限制血糖试纸市场的因素：

  • 对条带中使用塑胶的环境担忧可能会限制市场成长。

血糖试纸由塑胶製成，有环境问题。糖尿病患者的比例为1：11，而这些试纸是一次性使用的，所以它们总是可以帮助人们监测他们的糖尿病。随着不断的创新和技术改进，新技术和更好的技术始终面临威胁。血糖试纸是较经济的选择之一。

血糖试纸主要市场开拓

  • 2024年3月，诺瓦生物医学推出新一代「StatStrip」血糖医院计量系统。该产品提高了血糖检查的准确性，并采用 LINUX-OS 中的下一代计量系统。

血糖试纸市场细分与分析如下：

依糖尿病类型

  • 一型糖尿病
  • II型糖尿病

按分销管道

  • 在线的
  • 离线

按最终用户

  • 医院和诊所
  • 门诊手术中心
  • 诊断中心

按地区

  • 北美洲
  • 美国
  • 加拿大
  • 墨西哥
  • 南美洲
  • 巴西
  • 阿根廷
  • 其他的
  • 欧洲
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙
  • 其他的
  • 中东 中东/非洲
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 其他的
  • 亚太地区
  • 中国
  • 澳洲
  • 日本
  • 韩国
  • 印度
  • 泰国
  • 台湾
  • 印尼
  • 其他的

目录

第一章 简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关利益者的主要利益

第二章调查方法

  • 研究设计
  • 调查过程

第三章执行摘要

  • 主要发现

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

第五章血糖试纸市场：依糖尿病类型

  • 介绍
  • 1型糖尿病
  • 2型糖尿病

第六章血糖试纸市场：依通路

  • 介绍
  • 在线的
  • 离线

第七章血糖试纸市场：依最终用户分类

  • 介绍
  • 医院和诊所
  • 门诊手术中心
  • 诊断中心

第八章血糖试纸市场：按地区

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他的
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 其他的
  • 亚太地区
    • 中国
    • 澳洲
    • 日本
    • 韩国
    • 印度
    • 泰国
    • 台湾
    • 印尼
    • 其他的

第九章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第十章 公司简介

  • Abbott Diabetes Care
  • F. Hoffmann-La Roche Ltd
  • AgaMatrix, Inc.
  • Bayer
  • LifeScan IP Holdings, LLC
  • Care Touch USA
  • GenUltimate!
  • Arkray Inc
  • Metene
  • Medtronic
简介目录
Product Code: KSI061611895

The blood glucose test strips market is expected to grow to US$17.828 billion in 2029 from US$13.567 billion in 2024 at a 5.61% (CAGR)

Blood glucose test strips are plastic strips used to check the level of glucose in the blood. At one end of the strip, a sample of blood is put in, and it reacts with a chemical called glucose oxidase, producing gluconic acid. The metering algorithm then analyzes this acid to identify the blood glucose level.

The major factor driving the market expansion for such medical tools is the growing number of diabetic patients, followed by favorable efforts to bolster glucose monitoring technologies and the growing awareness regarding self-health. Moreover, market players' favorable investments in new testing strip launches have further led to an upward market trajectory.

However, the use of plastic for making test strips has raised certain environmental concerns about such tools, thereby hampering the overall market growth. Likewise, the stringent regulations laid by major authorities such as the Food and Drug Administration regarding test strip production and usage have also increased the level of technicalities for the product.

Blood Glucose Test Strips Market Drivers:

  • The growing prevalence of diabetes is expected to augment the overall market expansion.

Diabetes is becoming one of the major causes of death globally, with major economies witnessing a significant growth in their frequency of diabetic patients, both Type I and Type II. Such increasing prevalence of diabetes worldwide is considered the key driver for the blood glucose test strips market growth, as diabetes treatment requires consistent monitoring of blood glucose levels.

According to the International Federation of Diabetes, by 2030, nearly 643 million people will have diabetes. By 2045, this figure will reach 783 million, with the major type being type 2 diabetes. Moreover, the same source stated that in major regions such as Europe, 95% of the diabetic cases are of Type II diabetes, and by 2030, the total number of diabetic patients will reach 67 million, thereby showcasing a 9% growth over 2021's frequency of 61 million.

Major health organizations, namely the World Health Organization, suggest that the majority of diabetes cases occur in low to middle-income countries. Therefore, to monitor glucose levels in these countries, affordable testing options are needed. Blood glucose test strips, as compared to sensor-based monitors, are an affordable option and thus have a huge market in low and middle-income countries.

  • Favorable government initiatives to bolster diabetes monitoring are expected to drive market growth.

Blood glucose testing strips are easy to use, highly accurate, and affordable compared to other options available. Unlike sensor-based diabetes testing devices, which require medical intervention, blood glucose test strip devices can be used by individuals themselves.

Because of lifestyle changes and an increasing number of cases of diabetes in adults and children, the governments of countries and major health organizations are initiating strategies and schemes to bolster constant diabetes check-ups. For instance, in November 2022, the European Parliament adopted an EU-wide diabetes strategy to support diabetes diagnosis, research & treatment.

Likewise, according to the PIB August 2023 release, the Indian government, in collaboration with the Department of Health and Family Welfare, announced technical and financial support to states and union territories under the "National Health Mission." This aimed to bolster the prevention and screening of common non-communicable diseases, including diabetes, in the country.

  • Increasing awareness regarding diabetes has stimulated the market expansion.

Blood glucose testing strips have exceptional qualities, like being easy to use, high accuracy, and affordability compared to other options available. Diabetes testing is one of the most common preventative measures among people of all ages. With the start of COVID-19, the precautions have further increased, as it is life-threatening to diabetic and severe asthmatic patients. Thus, this caused an increase in the number of tests and a further increase in the usage of blood glucose testing strips.

Moreover, other factors, such as the booming adult population, have also stimulated market expansion since the adult population accounts for a major share of the global diabetic volume. For instance, according to a research study published in November 2023 in Diabetes Research and Clinical Practice, China accounts for a major share of adults having diabetes globally.

Blood Glucose Test Strips Market Geographical Outlook

  • Asia Pacific is set to account for a significant market share

The global blood glucose test strips market regionally is analyzed into North America, South America, Europe, Middle East and Africa, and Asia Pacific, where the APAC region is set to constitute a considerable market share as fuelled by the growing prevalence of diabetes in major regional economies namely China and India.

According to the International Federation of Diabetes, by 2030, the Asia Pacific region will account for 54% of the global diabetic population and 52% by 2045. Likewise, according to the "Indian Diabetes" research study published by the Indian Council of Medical Research, the prevalence of diabetes in the country reached 101 million. Moreover, as per Diabetes Australia, as of September 2023, nearly 1.5 million Australians have diabetes, and Type II accounted for a maximum portion of 86.7% of all cases. Hence, the same source specified that the frequency of newly registered cases reached 113,907 over the last twelve months.

Blood Glucose Test Strips Market Restraints:

  • Environmental concerns regarding plastic usage in strips can restrain the market growth.

Blood glucose test strips are made of plastic, which has environmental issues. With a ratio of 1 to 11 for diabetes, these test strips constantly help to monitor people's diabetes since they are one-time use and have their fair share of environmental concerns. With constant innovation and technological improvement, there is always a threat to new and better technology. Blood glucose test strips are one of the more economical options.

Blood Glucose Test Strips Key Market Developments

  • In March 2024, Nova Biomedical launched its new generation "StatStrip" glucose hospital meter system, which uses FDA-certified strips for blood glucose monitoring of critically ill patients. The product improves glucose-checking accuracy and features a LINUX-OS next-generation meter system.

The Blood Glucose Test Strips market is segmented and analyzed as given below:

By Diabetes Type

  • Type I Diabetes
  • Type II Diabetes

By Distribution Channel

  • Online
  • Offline

By End-User

  • Hospitals and Clinics
  • Ambulatory Surgery Centers
  • Diagnostics Centers

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • Australia
  • Japan
  • South Korea
  • India
  • Thailand
  • Taiwan
  • Indonesia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits for the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. BLOOD GLUCOSE TEST STRIPS MARKET BY DIABETES TYPE

  • 5.1. Introduction
  • 5.2. Type I Diabetes
  • 5.3. Type II Diabetes

6. BLOOD GLUCOSE TEST STRIPS MARKET BY DISTRIBUTION CHANNEL

  • 6.1. Introduction
  • 6.2. Online
  • 6.3. Offline

7. BLOOD GLUCOSE TEST STRIPS MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals and Clinics
  • 7.3. Ambulatory Surgery Centers
  • 7.4. Diagnostic Centers

8. BLOOD GLUCOSE TEST STRIPS MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. United States
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. UK
    • 8.4.4. Italy
    • 8.4.5. Spain
    • 8.4.6. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Israel
    • 8.5.4. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. Australia
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. India
    • 8.6.6. Thailand
    • 8.6.7. Taiwan
    • 8.6.8. Indonesia
    • 8.6.9. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Abbott Diabetes Care
  • 10.2. F. Hoffmann-La Roche Ltd
  • 10.3. AgaMatrix, Inc.
  • 10.4. Bayer
  • 10.5. LifeScan IP Holdings, LLC
  • 10.6. Care Touch USA
  • 10.7. GenUltimate!
  • 10.8. Arkray Inc
  • 10.9. Metene
  • 10.10. Medtronic